Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$16.59
-$0.10 (-0.6%)
Closing Price on November 26, 2024
TEVA Articles
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
May 6, 2016: Here are four stocks trading with heavy volume among 83 equities making new 52-week lows in Friday’s session. NYSE advancers led decliners by nearly 2 to 1 while Nasdaq decliners and...
Published:
Last Updated:
24/7 Wall St. is revisiting a strategy that was first published in late 2010, and then again refreshed in 2015. This is the 10 stocks to own for the decade!
Published:
Last Updated:
Credit Suisse's new Neutral rating on Teva Pharmaceutical Industries actually comes with significant upside.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Anadarko Petroleum, Dollar General, Encana, FedEx, Teva Pharmaceutical and UBS.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Published:
Last Updated:
The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest was mixed.
Published:
Last Updated:
March 18, 2016: Here are four stocks trading with heavy volume among 25 equities making new 52-week lows in Friday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped another...
Published:
Last Updated:
March 17, 2016: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped...
Published:
Last Updated:
One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be removed from the market, creating a huge risk and opportunity in...
Published:
Last Updated:
The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.
Published:
Last Updated:
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Published:
Last Updated:
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
Published:
Last Updated: